Search Results
#
aTyr Pharma Reports Promising Signals with Resolaris
Dec 20, 2016, 12:17 PM
Press release from aTyr.
#
aTyr Pharma ongoing Phase 1b/2 Clinical Trials
Oct 6, 2016, 9:46 AM
aTyr Pharma, a company engaged in the discovery and development of therapeutics to address severe rare diseases, is currently conducting two trials of Resolaris (ATYR1940) in patients with rare myopathies with an immune component.
#
aTyr announces initial results in FSHD trial
Apr 8, 2016, 2:39 PM
aTyr pharma has encouraging news regarding a possible treatment for FSHD using a novel protein-based biologic drug.